UTHR - Health Care Company United Therapeutics Announces Acquisition of Miromatrix Medical | Benzinga
United Therapeutics (NASDAQ:UTHR) has announced an acquisition of Miromatrix Medical (NASDAQ:MIRO) that is expected to be completed in Q4 of 2023.
Under the terms of the agreement, United Therapeutics has agreed to give Miromatrix Medical $91.00 million in cash in exchange for MIRO stock.
About The Companies Involved
United Therapeutics specializes in drug development for pulmonary arterial hypertension, a rare and progressive disease marked by abnormally high blood pressure in the arteries of the lungs. The company's therapies for PAH largely focus on the prostacyclin pathway, and many of its treatments are based on the same ...